Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Citigroup analyst Joanne Wuensch maintains Baxter Intl (NYSE:BAX) with a Neutral and lowers the price target from $26 to $21.
Goldman Sachs analyst David Roman maintains Baxter Intl (NYSE:BAX) with a Neutral and lowers the price target from $25 to $22.
UBS analyst Danielle Antalffy maintains Baxter Intl (NYSE:BAX) with a Neutral and lowers the price target from $24 to $21.
Argus Research analyst Jasper Hellweg downgrades Baxter Intl (NYSE:BAX) from Buy to Hold.
Baxter shares hit a 52-week low after cutting 2025 sales and earnings guidance despite posting better-than-expected third-quart...
Baxter Intl (NYSE:BAX) is looking for Q4 Adj EPS of $0.52-$0.57 vs $0.70 analyst estimate. sees sales of $2.808 billion vs $3.0...
Baxter Intl (NYSE:BAX) lowers FY2025 Adj EPS guidance from $2.42-$2.52 to $2.35-$2.40 vs $2.44 analyst estimate. Lowers FY2025 ...
Baxter Intl (NYSE:BAX) is looking for Q4 Adj EPS of $0.52-$0.57 vs $0.70 analyst estimate..
Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.60 by 15....
